Rou-Shayn Chen

848 total citations
18 papers, 601 citations indexed

About

Rou-Shayn Chen is a scholar working on Neurology, Cellular and Molecular Neuroscience and Cognitive Neuroscience. According to data from OpenAlex, Rou-Shayn Chen has authored 18 papers receiving a total of 601 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Neurology, 8 papers in Cellular and Molecular Neuroscience and 7 papers in Cognitive Neuroscience. Recurrent topics in Rou-Shayn Chen's work include Parkinson's Disease Mechanisms and Treatments (9 papers), Neurological diseases and metabolism (5 papers) and Neurological disorders and treatments (5 papers). Rou-Shayn Chen is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (9 papers), Neurological diseases and metabolism (5 papers) and Neurological disorders and treatments (5 papers). Rou-Shayn Chen collaborates with scholars based in Taiwan, United States and Netherlands. Rou-Shayn Chen's co-authors include Chin-Song Lu, Yi‐Hsin Weng, Yah‐Huei Wu‐Chou, Hsiu‐Chen Chang, Tu‐Hsueh Yeh, Erik Simons, Ben A. Oostra, Guido J. Breedveld, Marina van Doeselaar and Vincenzo Bonifati and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biochemical Pharmacology.

In The Last Decade

Rou-Shayn Chen

18 papers receiving 591 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rou-Shayn Chen Taiwan 14 425 184 184 171 104 18 601
Philippe Pals Belgium 11 376 0.9× 191 1.0× 188 1.0× 206 1.2× 140 1.3× 15 573
Barbara Jasińska‐Myga Poland 15 540 1.3× 202 1.1× 124 0.7× 138 0.8× 182 1.8× 29 710
Thamer Alkhairallah Saudi Arabia 7 462 1.1× 194 1.1× 138 0.8× 81 0.5× 52 0.5× 10 549
Susen Winkler Germany 15 559 1.3× 342 1.9× 124 0.7× 204 1.2× 76 0.7× 19 750
Janina Grosch Germany 9 364 0.9× 268 1.5× 188 1.0× 301 1.8× 136 1.3× 11 774
Kumar M. Prakash Singapore 13 332 0.8× 112 0.6× 69 0.4× 103 0.6× 116 1.1× 32 510
Jaione Irigoyen Spain 10 436 1.0× 178 1.0× 142 0.8× 120 0.7× 82 0.8× 11 597
Jinxia Zhou China 12 253 0.6× 122 0.7× 70 0.4× 181 1.1× 83 0.8× 32 576
Arlene R. Ng Philippines 12 406 1.0× 214 1.2× 111 0.6× 174 1.0× 80 0.8× 24 593
Thora Lohnau Germany 15 497 1.2× 295 1.6× 80 0.4× 219 1.3× 84 0.8× 16 709

Countries citing papers authored by Rou-Shayn Chen

Since Specialization
Citations

This map shows the geographic impact of Rou-Shayn Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rou-Shayn Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rou-Shayn Chen more than expected).

Fields of papers citing papers by Rou-Shayn Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rou-Shayn Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rou-Shayn Chen. The network helps show where Rou-Shayn Chen may publish in the future.

Co-authorship network of co-authors of Rou-Shayn Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Rou-Shayn Chen. A scholar is included among the top collaborators of Rou-Shayn Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rou-Shayn Chen. Rou-Shayn Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Wang, Hung‐Li, Ying‐Zu Huang, Yi‐Hsin Weng, et al.. (2020). Alda-1, an activator of ALDH2, ameliorates Achilles tendinopathy in cellular and mouse models. Biochemical Pharmacology. 175. 113919–113919. 23 indexed citations
2.
Chiu, Ching‐Chi, Hung‐Li Wang, Yi‐Hsin Weng, et al.. (2019). Generation of induced pluripotent stem cells from a young-onset Parkinson's disease patient carrying the compound heterozygous PLA2G6 p.D331Y/p.M358IfsX mutations. Stem Cell Research. 40. 101552–101552. 3 indexed citations
3.
Chiu, Ching‐Chi, Rou-Shayn Chen, Hua-Chien Chen, et al.. (2019). Upregulated Expression of MicroRNA-204-5p Leads to the Death of Dopaminergic Cells by Targeting DYRK1A-Mediated Apoptotic Signaling Cascade. Frontiers in Cellular Neuroscience. 13. 399–399. 42 indexed citations
4.
Wu, Hung-Ming, Fu‐Jung Hsiao, Rou-Shayn Chen, et al.. (2019). Attenuated NoGo-related beta desynchronisation and synchronisation in Parkinson’s disease revealed by magnetoencephalographic recording. Scientific Reports. 9(1). 7235–7235. 19 indexed citations
5.
Lin, Ming‐Shyan, Yi‐Hsin Weng, Tu‐Hsueh Yeh, et al.. (2019). Association of Antiviral Therapy With Risk of Parkinson Disease in Patients With Chronic Hepatitis C Virus Infection. JAMA Neurology. 76(9). 1019–1019. 42 indexed citations
6.
Wang, Hung‐Li, Chin-Song Lu, Tu‐Hsueh Yeh, et al.. (2019). Combined Assessment of Serum Alpha-Synuclein and Rab35 is a Better Biomarker for Parkinson's Disease. Journal of Clinical Neurology. 15(4). 488–488. 15 indexed citations
7.
Liu, Yo-Tsen, Hsiang‐Yu Yu, Kwong-Kum Liao, et al.. (2018). Aberrant Sensory Gating of the Primary Somatosensory Cortex Contributes to the Motor Circuit Dysfunction in Paroxysmal Kinesigenic Dyskinesia. Frontiers in Neurology. 9. 831–831. 9 indexed citations
9.
Lee, Wei‐Ju, Shey‐Lin Wu, Juei-Jueng Lin, et al.. (2016). PDD-5S: A useful screening tool for Parkinson's disease dementia. Parkinsonism & Related Disorders. 25. 85–90. 1 indexed citations
10.
Chiu, Ching‐Chi, Tu‐Hsueh Yeh, Szu‐Chia Lai, et al.. (2016). Increased Rab35 expression is a potential biomarker and implicated in the pathogenesis of Parkinson's disease. Oncotarget. 7(34). 54215–54227. 33 indexed citations
11.
Hsiao, Fu‐Jung, et al.. (2016). Abnormal Somatosensory Synchronization in Patients With Paroxysmal Kinesigenic Dyskinesia: A Magnetoencephalographic Study. Clinical EEG and Neuroscience. 48(4). 288–294. 13 indexed citations
12.
Chen, Rou-Shayn, et al.. (2014). Reduced Motor Cortex Deactivation in Individuals Who Suffer from Writer's Cramp. PLoS ONE. 9(5). e97561–e97561. 12 indexed citations
13.
Yeh, Tu‐Hsueh, Juei-Jueng Lin, Szu‐Chia Lai, et al.. (2012). Familial paroxysmal nonkinesigenic dyskinesia: Clinical and genetic analysis of a Taiwanese family. Journal of the Neurological Sciences. 323(1-2). 80–84. 18 indexed citations
14.
Wu‐Chou, Yah‐Huei, Ying‐Ting Chen, Tu‐Hsueh Yeh, et al.. (2012). Genetic variants of SNCA and LRRK2 genes are associated with sporadic PD susceptibility: A replication study in a Taiwanese cohort. Parkinsonism & Related Disorders. 19(2). 251–255. 34 indexed citations
15.
Yeh, Tu‐Hsueh, Szu‐Chia Lai, Yi‐Hsin Weng, et al.. (2012). Screening for C9orf72 repeat expansions in parkinsonian syndromes. Neurobiology of Aging. 34(4). 1311.e3–1311.e4. 19 indexed citations
16.
Lu, Chin-Song, Yah‐Huei Wu‐Chou, Marina van Doeselaar, et al.. (2008). The LRRK2 Arg1628Pro variant is a risk factor for Parkinson’s disease in the Chinese population. Neurogenetics. 9(4). 271–276. 50 indexed citations
17.
Fonzo, Alessio Di, Yah‐Huei Wu‐Chou, Chin-Song Lu, et al.. (2006). A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson’s disease risk in Taiwan. Neurogenetics. 7(3). 133–138. 180 indexed citations
18.
Yeh, Tu‐Hsueh, et al.. (2005). Autonomic Dysfunction in Machado-Joseph Disease. Archives of Neurology. 62(4). 630–630. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026